This invention relates to novel compounds that are dihydroindoles derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel dihydroindoles derivatives that are derivatives of silodosin. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an α-1A-adrenoreceptor antagonist, such as silodosin.
Vibrational Spectra of CF<sub>2</sub> = CHD and CF<sub>2</sub> = CD<sub>2</sub>
作者:Walter F. Edgell、Casper J. Ultee
DOI:10.1063/1.1739979
日期:1954.12
A method has been devised to prepare CF2 = CD2 and CF2 = CHD. The infrared spectra of the gaseous compounds and the Raman spectra of the liquids have been determined. The observed frequencies have been assigned to the fundamental modes of vibration and to overtones and combinations. The torsional frequency has been estimated as ca 720 and ca 520 cm—1 in CF2 = CH2 and CF2 = CD2, respectively. The overtone of the torsional frequency interacts with the CH2 or the CD2 deformation fundamental and this is the cause of the anomalous results with the product rule.
DEUTERATED DERIVATIVES OF SILODOSIN AS ALPHA IA-ADRENORECEPTOR ANTAGONISTS
申请人:Concert Pharmaceuticals Inc.
公开号:EP2125717A2
公开(公告)日:2009-12-02
Alpha 1A-adrenoceptor antagonists
申请人:Liu Julie F.
公开号:US20090012112A1
公开(公告)日:2009-01-08
This invention relates to novel compounds that are dihydroindoles derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel dihydroindoles derivatives that are derivatives of silodosin. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an α-
1
A-adrenoreceptor antagonist, such as silodosin.